Skip to content
← Childhood Esthesioneuroblastoma

HEALTH PROFESSIONAL · SOURCE READING

Treatment of Childhood Esthesioneuroblastoma

Source: Childhood Esthesioneuroblastoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: August 7, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

The use of multimodal therapy optimizes the chances for survival, with more than 70% of children expected to survive 5 or more years after initial diagnosis.[1-5] Neuromeningeal progression is the most common type of treatment failure.[5,6][Level of evidence C1]

Source links and citations

Treatment options according to Kadish stage include the following:[7]

Source links and citations

Kadish stage A: Surgery alone with clear margins. Adjuvant radiation therapy is indicated in patients with close and positive margins or with residual disease.

Kadish stage B: Surgery followed by adjuvant radiation therapy. The role of adjuvant chemotherapy is controversial.

Kadish stage C: Neoadjuvant approach with chemotherapy, radiation therapy, or concurrent chemoradiation therapy followed by surgery.

Kadish stage D: Systemic chemotherapy and radiation therapy to local and metastatic sites.

The mainstay of treatment is surgery and radiation therapy. However, esthesioneuroblastoma is a chemosensitive neoplasm, and the use of neoadjuvant chemotherapy can facilitate resection.[5,7-9] Endoscopic sinus surgery offers short-term outcomes similar to open craniofacial resection.[10]; [11][Level of evidence C2] Other techniques such as stereotactic radiosurgery and proton-beam therapy (charged-particle radiation therapy) may also play a role in the management of this tumor.[3,12,13]

Source links and citations

Routine neck dissection and nodal exploration are not indicated in the absence of clinical or radiological evidence of disease.[14] Management of cervical lymph node metastases has been addressed in a review article.[14]

Source links and citations

Reports have indicated promising results with the increased use of resection and neoadjuvant or adjuvant chemotherapy in patients with advanced-stage disease.[2,5,15-17]; [18][Level of evidence C1] Chemotherapy regimens that have been used with efficacy include the following:

Source links and citations

Cisplatin and etoposide with or without ifosfamide.[19,20]

Source links and citations

Vincristine, dactinomycin, and cyclophosphamide with or without doxorubicin.

Ifosfamide and etoposide.

Cisplatin plus etoposide or doxorubicin.[2]

Source links and citations

Vincristine, doxorubicin, and cyclophosphamide.[21]

Source links and citations

Irinotecan plus docetaxel.[22][Level of evidence C1]

Source links and citations

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice